Drug Shortage Report for PANTOPRAZOLE SODIUM FOR INJECTION

Last updated on 2020-03-30 History
Report ID 67602
Drug Identification Number 02306727
Brand name PANTOPRAZOLE SODIUM FOR INJECTION
Common or Proper name PANTOPRAZOLE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PANTOPRAZOLE
Strength(s) 40MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-11-12
Estimated end date 2020-01-31
Actual end date 2020-02-04
Shortage status Resolved
Updated date 2020-03-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2020-03-30 French Compare
v18 2020-03-30 English Compare
v17 2020-01-22 French Compare
v16 2020-01-22 English Compare
v15 2019-09-10 French Compare
v14 2019-09-10 English Compare
v13 2019-06-12 French Compare
v12 2019-06-12 English Compare
v11 2019-05-07 French Compare
v10 2019-05-07 English Compare
v9 2019-04-15 French Compare
v8 2019-04-15 English Compare
v7 2019-04-15 English Compare
v6 2019-01-16 French Compare
v5 2019-01-16 English Compare
v4 2018-12-13 French Compare
v3 2018-12-13 English Compare
v2 2018-11-26 French Compare
v1 2018-11-26 English Compare

Showing 1 to 19 of 19